new_0222_0712|EVAX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0712|EVAX|1|Evaxion Biotech AS Total Current Assets (Quarterly) (USD)|Evaxion Biotech AS Cash and Short Term Investments (Quarterly) (USD)|Evaxion Biotech AS Inventories (Quarterly) (USD)|Evaxion Biotech AS Net PP&E (Quarterly) (USD)|Evaxion Biotech AS Goodwill and Intangibles (Quarterly) (USD)|Evaxion Biotech AS Total Liabilities (Quarterly) (USD)|Evaxion Biotech AS Total Current Liabilities (Quarterly) (USD)|Evaxion Biotech AS Total Long Term Liabilities (Quarterly) (USD)|Evaxion Biotech AS Total Deposits (Quarterly) (USD)|Evaxion Biotech AS Book Value (Quarterly) (USD)|Evaxion Biotech AS Retained Earnings (Quarterly) (USD)|Evaxion Biotech AS Treasury Stock (Quarterly) (USD)|Evaxion Biotech AS EV to Revenues|Evaxion Biotech AS EV to Earnings|Evaxion Biotech AS EV to Free Cash Flow|Evaxion Biotech AS EV to Assets (Quarterly)|Evaxion Biotech AS PS Ratio|Evaxion Biotech AS PE Ratio|Evaxion Biotech AS Price to Book Value|Evaxion Biotech AS PEG Ratio|Evaxion Biotech AS Debt to Equity Ratio|Evaxion Biotech AS Dividend Yield|Evaxion Biotech AS Shareholder Yield (TTM)|Evaxion Biotech AS Percent of Shares Outstanding Short|Evaxion Biotech AS Total Receivables (Quarterly) (USD)|Evaxion Biotech AS Total Payables (Quarterly) (USD)|Evaxion Biotech AS Total Capital Stock (Quarterly) (USD)|Evaxion Biotech AS Return on Invested Capital|Evaxion Biotech AS Quality Ratio Score|Evaxion Biotech AS Momentum Score|Evaxion Biotech AS Beta (1Y)|Evaxion Biotech AS Sustainable Growth Rate (TTM)|Evaxion Biotech AS Institutional Investor Ownership Percentage|Evaxion Biotech AS Average Diluted Shares Outstanding (Quarterly)|Evaxion Biotech AS Total Employees (Annual)|Evaxion Biotech AS EPS Diluted (Quarterly) (USD)|Evaxion Biotech AS SG&A Expense (Quarterly) (USD)|Evaxion Biotech AS Shares Outstanding|Evaxion Biotech AS Repurchase of Capital Stock (Quarterly) (USD)|Evaxion Biotech AS Ordinary Shares Number (Quarterly)|Evaxion Biotech AS Payout Ratio|Evaxion Biotech AS Quick Ratio (Quarterly)|Evaxion Biotech AS Normalized Diluted EPS (Quarterly) (USD)|Evaxion Biotech AS Stock Buybacks (Quarterly) (USD)|Evaxion Biotech AS Effective Tax Rate (TTM)|Evaxion Biotech AS Return on Equity|Evaxion Biotech AS Net Income (TTM) (USD)|Evaxion Biotech AS Revenue (TTM) (USD)|Evaxion Biotech AS Dividend Per Share (Quarterly) (USD)|Evaxion Biotech AS Revenue (Quarterly) (USD)|Evaxion Biotech AS Gross Profit (Quarterly) (USD)|Evaxion Biotech AS Pre-Tax Income (Quarterly) (USD)|Evaxion Biotech AS Net Income (Quarterly) (USD)|Evaxion Biotech AS Net Interest Income (Quarterly) (USD)|Evaxion Biotech AS Price (USD)|Evaxion Biotech AS Total Return Price (USD)|Evaxion Biotech AS Enterprise Value (USD)|Evaxion Biotech AS 30-Day Average Daily Volume|Evaxion Biotech AS 1 Year Price Returns (Daily)|Evaxion Biotech AS Short Interest|Evaxion Biotech AS PE Ratio (Forward)|Evaxion Biotech AS PE Ratio (Forward 1y)|Evaxion Biotech AS PS Ratio (Forward)|Evaxion Biotech AS PS Ratio (Forward 1y)|Evaxion Biotech AS Quarterly EPS Estimates (USD)|Evaxion Biotech AS Quarterly Revenue Estimates (USD)|Evaxion Biotech AS Quarterly EPS Surprise|Evaxion Biotech AS Quarterly Revenue Surprise|Evaxion Biotech AS Quarterly Actual EPS (USD)|Evaxion Biotech AS Quarterly Actual Revenue (USD)|Evaxion Biotech AS Revenue Estimates for Current Fiscal Year (USD)|Evaxion Biotech AS Revenue Estimates for Next Fiscal Year (USD)|Evaxion Biotech AS Price Target (USD)|Evaxion Biotech AS Consensus Recommendation|Evaxion Biotech AS Price Target Num Estimates|Evaxion Biotech AS EPS Estimates for Current Fiscal Year (USD)|Evaxion Biotech AS EPS Estimates for Next Fiscal Year (USD)|Evaxion Biotech AS Research and Development Expense (Quarterly) (USD)|Evaxion Biotech AS Reconciled Depreciation (Quarterly) (USD)|Evaxion Biotech AS Non-Operating Interest Expense (Quarterly) (USD)|Evaxion Biotech AS Land and Improvements (Quarterly) (USD)|Evaxion Biotech AS Buildings and Improvements (Quarterly) (USD)|Evaxion Biotech AS Other Properties (Quarterly) (USD)|Evaxion Biotech AS Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0712|EVAX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0712|EVAX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0712|EVAX|5|127.8|127.8||127.8|127.8|127.8|127.8|127.8||127.8|127.8||||1.4427480916||||1.4427480916|||1.4427480916||15.347826087|127.8|127.8|127.8||||||30.6|91.2857142857||91.2857142857|91.2857142857|39.125||127.8|||91.2857142857|91.3333333333|91.25||91.25|||||91.2857142857|91.2857142857|91.2857142857|1.4427480916|1.4427480916|1.4427480916|1.44206008584|1.22222222222|15.347826087|||||91.25|91.25|91.5||91.5|91|32.5833333333|31.625|28.1|22|28.1|30.6666666667|28.1111111111|91.2857142857||91.2857142857|||127.8|||
new_0222_0712|EVAX|6|5|5||5|5|5|5|5||5|5||||262||||262|||262||23|5|5|5||||||10|7||7|7|8||5|||7|6|4||4|||||7|7|7|262|262|262|233|9|23|||||4|8|2||2|3|12|8|10|15|10|12|9|7||7|||5|||
new_0222_0712|EVAX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0712|EVAX|201912|10.958|9.559||0.126||1.722|1.722|||9.362|-15.812||||||||||||||0.931|1.411|2.481|||||||19.1987||-0.1833|0.761|||16.1987|||-0.1833|||||||||-3.778|-3.519|-0.111||||||||||||||||||||||||2.946|0.03|0.036|||0.272|||
new_0222_0712|EVAX|202003||||||||||||||||||||||||||||||||||19.1987||-0.1614|0.781||||||-0.1614|||||||||-3.279|-3.099|0.012||||||||||||||||||||||||2.51||0.004||||||
new_0222_0712|EVAX|202006||||||||||||||||||||||||||||||||||19.1987||-0.1896|1.372||||||-0.1896|||||||||-3.936|-3.64|0.006||||||||||||||||||||||||2.57||||||||
new_0222_0712|EVAX|202009|10.413|7.876||0.213|0.037|3.372|3.372|||7.903|-23.767||||||||||||||0.475|3.334|2.603|||||||16.1987||-0.2476|1.719|||16.1987|||-0.2476|-6.626|8.4269||-14.268|||||-4.588|-4.01|0.097||||||||||||||||||||||||2.966||0.003|||0.166|||
new_0222_0712|EVAX|202012|10.95|5.834||0.457|0.1|4.927|4.927|||7.038|-27.279||||-9.9893||||19.0405|||||0.0285|1.794|3.853|2.648|||||||16.1987|35|-0.2635|1.782|16.1987||16.1987|||-0.2635|-2.394|9.3937||-15.018|||||-4.772|-4.269|-0.144|6.98|6.98|128.1729|||5473|||||-0.25|||||||||||-0.95||2.856||0.022|||0.52|||
new_0222_0712|EVAX|202103|32.487|26.955||1.793|0.096|7.121|6.016|1.105||27.799|-31.078||||-6.0813||||4.0747|||||0.017|1.612|5.961|3.132||||||4.6044|17.8653||-0.23|1.282|19.1987||19.1987|||-0.23|-27.9|10.0247||-16.012|||||-4.5|-4.093|0.675|5.9|5.9|86.3173|86232.6667||3260|||||-0.33||30.303||-0.23||||20.5|1|2|-1.21|-1.76|3.893||0.297|||1.6||7.13|6.74
new_0222_0712|EVAX|202106|23.425|18.799||2.276|0.097|5.828|4.801|1.027||21.829|-37.471||||-6.541||||6.8074|||||0.146|1.797|4.665|3.132||||||2.2895|19.1987||-0.36|1.915|19.1987||19.1987|||-0.36||10.104||-19.191|||||-7.488|-6.819|-0.462|7.74|7.74|129.7989|123011.5||28034|||||-0.295||-22.0339||-0.36||||20.5|1|2|-1.205|-1.8|5.111||0.495|||2.076||5.4|6.53
new_0222_0712|EVAX|202109|16.317|11.944||5.35|0.095|7.466|3.922|3.544||16.65|-42.14||||-7.357||||11.1156|||||0.203|1.719|3.444|3.132||||||1.7825|19.4444||-0.27|1.495|19.1987||19.1987|||-0.27|-0.001|8.9325||-20.431|||||-5.675|-5.25|0.237|9.64|9.64|174.3905|163044.1667||38965|||||-0.345||21.7391||-0.27||||19|1|3|-1.31|-1.83|4.417||0.051|||5.156||7.61|4.66
new_0222_0712|EVAX|202112|||||||||||||||-3.8643||||6.1433|||||0.1671|||||||||1.4788||||||||||||||||||||||4.42|4.42|91.6004|218249|-65.3625|38676|||||-0.3||||||||16.25|1|4|-1.17|||||||||3.14|3.01
new_0222_0712|EVAX|202203||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
new_0222_0712|EVAX|202206||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
new_0222_0712|EVAX|202209||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
new_0222_0712|EVAX|202212||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||